ERFSF Stock Recent News

EUROFINS SCIENT (ERFSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharg.

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharg.

Eurofins Scientific delivered strong Q1 revenue growth and robust 2024 cash flow, supporting confidence in its 2025 and 2027 guidance. The company is executing well on organic growth and M&A, with a clear path to higher margins and free cash flow per share. Management reconfirmed ambitious targets: 6.5% organic growth, 24% EBITDA margin, and significant EPS/free cash flow expansion by 2027.

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharg.

Eurofins Scientific SE (OTCPK:ERFSF) Q2 2025 Earnings Conference Call April 23, 2025 9:00 AM ET Company Participants Gilles Martin - Chairman and CEO Laurent Lebras - Group Administration and CFO Conference Call Participants Remi Grenu - Morgan Stanley Suhasini Varanasi - Goldman Sachs Delphine Le Louet - Bernstein Neil Tyler - Redburn Atlantic Arthur Truslove - Citi Allen Wells - Jefferies Pablo Cuadrado - Kepler Unidentified Company Representative Ladies and gentlemen, welcome and thank you for joining Eurofins' Q1 2025 Trading Update Presentation. Please note that this call is being recorded and will later be available for replay on the Eurofins Investor Relations' website.

Here is how EUROFINS SCIENT (ERFSF) and Genelux Corporation (GNLX) have performed compared to their sector so far this year.

EUROFINS SCIENT (ERFSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here is how EUROFINS SCIENT (ERFSF) and Abbott (ABT) have performed compared to their sector so far this year.

Eurofins Scientific SE (OTCPK:ERFSF) Q4 2024 Earnings Call Transcript January 30, 2025 9:00 AM ET Company Participants Gilles Martin - Chairman of the Board & Chief Executive Officer Laurent Lebras - Group Administration and Chief Financial Officer Conference Call Participants Annelies Vermeulen - Morgan Stanley Suhasini Varanasi - Goldman Sachs Pablo Cuadrado - Kepler Cheuvreux James Clark - Barclays Himanshu Agarwal - Bank of America Allen Wells - Jefferies Arthur Truslove - Citi Operator Ladies and gentlemen, welcome, and thank you for joining Eurofins' FY 2024 Results Presentation. Please note that this call is being recorded and will later be available for replay on the Eurofins Investor Relations website.